Non-implantable medical devices encompass a broad range of products, including diagnostic instruments, monitoring devices, therapeutic equipment, and consumables used across hospital, outpatient, and homecare settings. Companies in this segment operate in an environment shaped by evolving regulatory frameworks, stringent safety and quality standards, and increasing competitive pressure. Adoption is driven by clinical performance, ease of use, cost-effectiveness, and compatibility with existing care pathways and infrastructure, as well as procurement processes in hospitals and healthcare systems.

Innovation cycles are accelerating, with advancements in digital health, connected devices, point-of-care diagnostics, and minimally invasive technologies transforming product offerings and care delivery models. In parallel, shorter product lifecycles and increasing price sensitivity require continuous portfolio optimization and differentiation. Geopolitical factors, including trade policies, import tariffs, and regulatory variability across markets, influence market access, pricing strategies, and supply chain decisions. Companies must balance cost competitiveness, scalability, and operational efficiency, while delivering reliable, user-friendly solutions that meet the evolving needs of hospitals, clinics, and homecare providers.

We help medical device companies address these challenges across the full spectrum of strategic and operational capabilities. 

  • Corporate Strategy: we support global strategy development, portfolio prioritization, business model innovation, market opportunity assessment, growth planning, market entry, partnerships, and turnaround initiatives tailored to medical devices markets. 
  • Customer Insights: we map stakeholders including clinicians, hospital administrators, and procurement teams, capture the voice of customers, and refine value propositions.
  • Commercial Strategy: we design go-to-market models, launch readiness plans, commercial excellence programs, competitive benchmarking, and differentiation strategies. 
  • Medical Affairs: we provide guidance on evidence generation, clinical validation, and engagement with healthcare professionals to accelerate adoption. 
  • Market Access: we advise on global access strategies, pricing and tender strategies and value-based healthcare frameworks to support adoption and coverage. 
  • R&D and Innovation: we optimize innovation sourcing, portfolio prioritization, lifecycle management, and R&D processes to accelerate product development and differentiation. 
  • M&A and Transactions: we conduct commercial and vendor due diligence, build-up strategies, acquisition planning, and post-merger integration to expand capabilities and market reach. 

By combining deep sector knowledge with end-to-end strategy and operational support, we help medical device companies accelerate growth, optimize portfolios, navigate regulatory and geopolitical complexity, enhance adoption and clinical impact, and deliver sustainable value to healthcare providers and patients.